Evidence map›Paper›PMID 40846780›Full record

ArticleCommunications medicine2025

Using the PET/CT radiotracer [

Somit Pandey, Rama Walia, Gurvinder Kaur, Kumud Pandav, Imran Rather, Nivedita Rana, Sushant Sahoo, Bhagwant Rai Mittal, Jaya Shukla

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Functional pituitary adenoma imaging.Reviews in endocrine & metabolic disorders · 2026
    Review
  2. Synthesis of [RSC advances · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Somit PandeyDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India.
Rama WaliaDepartment of Endocrinology, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India. ramawaliapgimer@gmail.com.
Gurvinder KaurDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India.
Kumud PandavDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India.ORCID http://orcid.org/0000-0002-4513-1739
Imran RatherDepartment of Pharmacology, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India.
Nivedita RanaDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India.
Sushant SahooDepartment of Neurosurgery, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India.
Bhagwant Rai MittalDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India.
Jaya ShuklaDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education & Research (P.G.I.M.E.R), Chandigarh, India. shuklajaya@gmail.com.ORCID http://orcid.org/0000-0003-3355-4168

Funding

Department of Science and Technology, Ministry of Science and Technology (DST) TDP/BDTD/59/2021
6 · The paper itself

Abstract

backgroundCushing's disease, the most common cause of Cushing's syndrome, is driven by pituitary tumors (corticotropinoma) and characterized by the overexpression of CRH R1 and V1b receptors. Accurate detection of these tumors remains challenging. This study aims to develop and evaluate a corticotropinoma specific radiopharmaceutical, [

methodsMolecular docking was used to validate the binding affinity of [

resultsHere we show that [

conclusionsThese finding support [

Identifiers

PMID40846780
PMCPMC12373759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.